Clinical Research Directory

BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction

Sponsor: Northwestern University

Summary

This study will determine if primary graft dysfunction (which causes low blood oxygen levels and fluid or inflammation in the lungs) after lung transplant can be prevented through the use of the study drug (IL-1 receptor antagonist, Anakinra). In this study, lung transplant participants who are randomized to the treatment group will have the study drug injected into the solution that their donor lungs are kept in prior to transplant.

Key Details

Conditions

Interventions

Locations (1)